American Journal of Psychiatry · 1977 · 72 citations · 9 references
PharmacyPharmacologyPharmacotherapyNeuropharmacologyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyNaloxone TherapySchizophrenia PharmacotherapySchizophrenia Spectrum DisordersAntipsychotic ActionAntipsychotic Medication ManagementAtypical Antipsychotic TreatmentPsychosis PharmacotherapyPsychostimulant Pharmacotherapy
The authors treated 12 schizophrenic patients who had overt hallucinatory symptoms with intravenously administered naloxone hydrochloride, a narcotic antagonist purported to have antihallucinatory properties. They found no evidence of the effectiveness of naloxone in preventing hallucinations over that of placebo when administered in a randomized, double-blind fashion.
9
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Joel W. Hughes, Terry Smith, H. W. Kosterlitz et al. · Nature · 1975 · 3.8K citations
Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness
Floyd E. Bloom, David J. Segal, Nicholas Ling et al. · Science · 1976 · 812 citations
Medicine, Neuroscience, Pharmacology +17
Opioid Peptides Endorphins in Pituitary and Brain
Avram Goldstein · Science · 1976 · 516 citations
Increased CSF levels of endorphines in chronic psychosis
Lars Terenius, Agneta Wahlström, L. Lindström et al. · Neuroscience Letters · 1976 · 267 citations